Skip to main content
    C

    Cellebrite DI (CLBT)

    Official site

    TECHNOLOGY • SOFTWARE - INFRASTRUCTURE • NASDAQ

    $11.12
    -0.41 (-3.56%)

    Market Cap: $2.90B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Cellebrite DI (CLBT) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Cellebrite DI reported revenue of $475.68M for the fiscal year ended Dec 31, 2025, up 18.6% from the year before. That year, net income was $78.33M with a net margin of 16.5%, operating cash flow was $168.96M and free cash flow was $155.73M. The quarter ended Sep 30, 2026 had revenue of $149.02M and net income of $26.66M.

    Revenue and Margins

    The operating margin was 14.0% in the fiscal year ended Dec 2025. Over the 6 years to Dec 2025, revenue grew from $171.85M, a compound annual rate of 18.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$475.68M+18.6%84.2%14.0%16.5%
    Dec 2024$401.20M+23.4%84.4%14.2%-70.5%
    Dec 2023$325.11M+20.1%83.6%10.2%-24.9%
    Dec 2022$270.65M+9.9%81.3%0.4%44.6%
    Dec 2021$246.25M+26.3%82.7%5.6%29.0%
    Dec 2020$194.91M+13.4%80.6%4.7%3.0%
    Dec 2019$171.85MN/A79.2%-0.9%-1.1%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 32.0% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$475.68M$401.20M$325.11M$270.65M$246.25M$194.91M$171.85M
    Cost of revenue$75.17M$62.59M$53.23M$50.75M$42.56M$37.88M$35.82M
    Gross profit$400.50M$338.61M$271.88M$219.91M$203.69M$157.03M$136.03M
    Research and development$113.88M$98.42M$84.39M$80.62M$65.54M$54.38M$46.57M
    Operating income$66.48M$56.91M$33.24M$1.04M$13.82M$9.22M-$1.52M
    Net income$78.33M-$283.01M-$81.10M$120.81M$71.40M$5.78M-$1.88M
    EBITDA$103.07MN/AN/A$130.10M$89.47M$17.28M$5.62M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$149.02M$131.14M$128.30M$128.82M$126.03M$113.28M$107.55M$109.05M$106.86M$95.71M$89.58M$93.01M
    Gross profit$121.05M$105.93M$105.88M$109.13M$105.72M$95.60M$90.06M$91.42M$91.41M$79.45M$76.32M$78.10M
    Operating income$26.88M$7.63M$9.12M$20.80M$18.99M$14.42M$12.27M$15.73M$19.45M$12.49M$9.25M$15.00M
    Net income$26.66M$6.37M$10.94M$21.26M$20.19M$19.48M$17.40M$19.27M-$207.09M-$23.81M-$71.37M-$14.65M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $4.00M by $120.46M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$938.85M$690.57M$532.88M$403.29M$339.78M$364.39M$280.24M
    Current assets$575.85M$567.59M$422.08M$295.93M$273.21M$324.27M$261.88M
    Cash and equivalents$124.46M$191.66M$189.52M$87.64M$145.97M$128.71M$76.55M
    Total liabilities$454.53M$354.55M$498.67M$329.43M$413.13M$300.58M$221.41M
    Short-term debt$4.00M$4.13M$4.97M$5.00MN/AN/AN/A
    Shareholder equity$484.32M$336.02M$34.21M$73.86M-$73.35M$63.80M$58.83M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$1.07B$994.31M$952.29M$938.85M$834.32M$787.42M$709.89M$690.57M$629.25M$556.58M$529.14M$532.88M
    Total liabilities$489.18M$456.21M$441.75M$454.53M$386.63M$379.01M$346.40M$354.55M$330.93M$596.74M$555.84M$498.67M
    Cash and equivalents$223.06M$141.25M$133.69M$124.46M$281.36M$179.22M$90.47M$191.66M$136.35M$106.96M$122.43M$189.52M
    Shareholder equity$579.31M$538.10M$510.54M$484.32M$447.69M$408.41M$363.49M$336.02M$298.32M-$40.16M-$26.71M$34.21M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 92.2% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow$168.96M$132.17M$102.06M$20.58M$36.05M$66.51M$16.13M
    Capital expenditures$13.22M$10.61M$7.92M$9.09M$8.11M$6.18M$6.21M
    Free cash flow$155.73M$121.56M$94.14M$11.49M$27.94M$60.33M$9.92M
    Dividends paidN/AN/A$0$0$100.00M$10.00M$25.00M
    Investing cash flow-$268.25M-$149.47M-$22.54M-$91.23M$45.23M-$6.45M-$46.72M
    Financing cash flow$29.64M$20.65M$21.77M$13.97M-$68.40M-$8.59M$75.54M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$56.58M$17.59M$19.89M$82.23M$33.27M$32.58M$20.88M$65.97M$41.65M$14.51M$10.04M$43.83M
    Capital expenditures$4.78M$3.07M$3.04M$3.96M$3.32M$3.61M$2.34M$4.32M$1.82M$2.35M$2.12M$4.95M
    Free cash flow$51.80M$14.52M$16.84M$78.27M$29.95M$28.98M$18.54M$61.65M$39.83M$12.16M$7.92M$38.88M
    Last 12 quarters

    Frequently Asked Questions About CLBT

    What is Cellebrite DI's annual revenue?

    Cellebrite DI reported revenue of $475.68M for the fiscal year ended Dec 31, 2025.

    How fast is Cellebrite DI's revenue growing?

    Revenue was up 18.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 20.7%.

    Is Cellebrite DI profitable?

    Yes. Cellebrite DI reported net income of $78.33M for the fiscal year ended Dec 31, 2025, with a net margin of 16.5%.

    How much free cash flow does CLBT generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $168.96M minus capital expenditures of $13.22M produced free cash flow of $155.73M.

    How much debt does Cellebrite DI have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $4.00M and cash and equivalents of $124.46M.